Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
University of Louisville, Clinical Trials Unit
188
mi
from 43215
Louisville, KY
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
University of Louisville, Clinical Trials Unit
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
MGG Group, Co. Inc./Chevy Chase Clinical Research
324
mi
from 43215
Chevy Chase, MD
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
MGG Group, Co. Inc./Chevy Chase Clinical Research
324
mi
from 43215
Chevy Chase, MD
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
'Rapid City Medical Center
1072
mi
from 43215
Rapid City, SD
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
'Rapid City Medical Center
1072
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
WR-ClinSearch, LLC
359
mi
from 43215
Chattanooga, TN
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
WR-ClinSearch, LLC
359
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Gastro One
501
mi
from 43215
Germantown, TN
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Gastro One
501
mi
from 43215
Germantown, TN
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center - IBD Clinic
334
mi
from 43215
Nashville, TN
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center - IBD Clinic
334
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Associates in Research Therapeutics of America, LLC
1138
mi
from 43215
San Antonio, TX
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Associates in Research Therapeutics of America, LLC
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Research Of San Antonio
1138
mi
from 43215
San Antonio, TX
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Research Of San Antonio
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
TDDC San Marcos
1094
mi
from 43215
San Marcos, TX
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
TDDC San Marcos
1094
mi
from 43215
San Marcos, TX
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
University of Virginia Health System
275
mi
from 43215
Charlottesville, VA
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Center, LLC
278
mi
from 43215
Charlottesville, VA
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Center, LLC
278
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
McGuire DVAMC, GI (111N)
342
mi
from 43215
Richmond, VA
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
McGuire DVAMC, GI (111N)
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Instituto de Investigaciones Clinicas Mar del Plata
mi
from 43215
Mar del Plata,
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Instituto de Investigaciones Clinicas Mar del Plata
mi
from 43215
Mar del Plata,
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research US, Inc./Wasatch Peak Family Practice
1515
mi
from 43215
Layton, UT
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research US, Inc./Wasatch Peak Family Practice
1515
mi
from 43215
Layton, UT
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
MedStar Georgetown University Hospital
328
mi
from 43215
Washington,
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
MedStar Georgetown University Hospital
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Tibor Rubin VA Medical Center
1972
mi
from 43215
Long Beach, CA
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Tibor Rubin VA Medical Center
1972
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Emeritas Research Group
mi
from 43215
Lansdowne, VA
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Emeritas Research Group
mi
from 43215
Lansdowne, VA
Click here to add this to my saved trials
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
PPD Development
1069
mi
from 43215
Austin, TX
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
PPD Development
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1158
mi
from 43215
Aurora, CO
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1158
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
Feinberg School of Medicine, Northwestern University
274
mi
from 43215
Chicago, IL
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
Feinberg School of Medicine, Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
Carle Foundation Hospital
274
mi
from 43215
Urbana, IL
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
Carle Foundation Hospital
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
Atlantic Health System
453
mi
from 43215
Morristown, NJ
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
Atlantic Health System
453
mi
from 43215
Morristown, NJ
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
1978
mi
from 43215
Mission Hills, CA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
1978
mi
from 43215
Mission Hills, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
1924
mi
from 43215
Rialto, CA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
1924
mi
from 43215
Rialto, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
978
mi
from 43215
Hollywood, FL
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
433
mi
from 43215
Decatur, GA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
423
mi
from 43215
Marietta, GA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
423
mi
from 43215
Marietta, GA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
800
mi
from 43215
Baton Rouge, LA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
800
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
165
mi
from 43215
Ann Arbor, MI
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
165
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera investigational site
430
mi
from 43215
Greenville, NC
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera investigational site
430
mi
from 43215
Greenville, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
366
mi
from 43215
Sayre, PA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
366
mi
from 43215
Sayre, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site.
991
mi
from 43215
Houston, TX
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site.
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera investigational site
1138
mi
from 43215
San Antonio, TX
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera investigational site
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
416
mi
from 43215
Philadelphia, PA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
993
mi
from 43215
Miami, FL
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
274
mi
from 43215
Chicago, IL
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
188
mi
from 43215
Louisville, KY
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
280
mi
from 43215
Brooklyn, NY
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
280
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
408
mi
from 43215
Union City, TN
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
408
mi
from 43215
Union City, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
mi
from 43215
Victoria,
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
mi
from 43215
Victoria,
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
623
mi
from 43215
Little Rock, AR
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
413
mi
from 43215
Flourtown, PA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
413
mi
from 43215
Flourtown, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
332
mi
from 43215
Nashville, TN
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
1973
mi
from 43215
Long Beach, CA
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
1973
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
442
mi
from 43215
New York, NY
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Lycera Investigational Site
482
mi
from 43215
Bronx, NY
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Lycera Investigational Site
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials